10 months ago
STVN
AnalystsDerik De BruinDerik De Bruin's Stock Forecasts
AnalystsDerik De Bruin
Analyst Ranking
Top 11%
#488 out of 4554 analysts
Average Return
+9.21%
Win Rate
59%46 out of 78
Risk vs Reward
Poor
Good
Derik De Bruin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +122.87% | $51.63 | $115.07 | 2018-08-01 - 2019-08-02 | Strong Buy |
Hologic IncHOLX | +118.26% | $34.06 | $74.34 | 2020-04-01 - 2021-04-01 | Strong Buy |
Talis Biomedical CorpTLIS | +84.89% | $49.65 | $7.50 | 2022-01-06 - 2023-01-06 | Sell |
Iqvia Holdings IncIQV | +78.91% | $141.94 | $253.94 | 2020-07-06 - 2021-07-07 | Strong Buy |
Exact Sciences CorpEXAS | +77.58% | $65.96 | $117.13 | 2018-07-22 - 2019-07-23 | Strong Buy |
Derik De Bruin Analyst Color
Get additional color on Derik De Bruin's coverage of popular stocks
10 months ago
WST
2 years ago
A
Derik De Bruin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Fortrea Holdings IncFTRE | 2 | Sell | $33.00 | -8.33% | Maintains | a month ago |
Schrodinger IncSDGR | 1 | Hold | $32.00 | +31.47% | Maintains | 2 months ago |
Illumina IncILMN | 4 | Sell | $100.00 | -14.30% | Downgrades | 4 months ago |
Agilent Technologies IncA | 12 | Hold | $133.00 | +0.42% | Downgrades | 4 months ago |
Quest Diagnostics IncDGX | 4 | Strong Buy | $160.00 | +27.07% | Upgrades | 4 months ago |
10x Genomics IncTXG | 4 | Hold | $54.00 | +86.53% | Upgrades | 4 months ago |
Thermo Fisher Scientific IncTMO | 12 | Strong Buy | $575.00 | +6.18% | Maintains | 6 months ago |
Laboratory Corp Of America HoldingsLH | 2 | Strong Buy | $230.00 | +15.32% | Maintains | 7 months ago |
Catalent IncCTLT | 7 | Sell | $46.00 | -17.56% | Maintains | 8 months ago |
Charles River Laboratories International IncCRL | 3 | Strong Buy | $245.00 | +7.67% | Maintains | 8 months ago |
Hologic IncHOLX | 6 | Hold | $86.00 | +14.51% | Maintains | 9 months ago |
Stevanato Group SpaSTVN | 2 | Strong Buy | $35.00 | +23.24% | Maintains | 10 months ago |
EVO | 1 | Hold | $13.00 | +42.70% | Downgrades | 10 months ago |
West Pharmaceutical Services IncWST | 4 | Strong Buy | $405.00 | +7.33% | Upgrades | 10 months ago |
Waters CorpWAT | 6 | Hold | $315.00 | +7.06% | Maintains | a year ago |
Exact Sciences CorpEXAS | 5 | Strong Buy | $88.00 | +38.63% | Maintains | a year ago |
Mettler Toledo International IncMTD | 4 | Hold | $1,525.00 | +27.88% | Maintains | a year ago |
Danaher CorpDHR | 1 | Hold | $250.00 | +5.77% | Downgrades | a year ago |
Neogenomics IncNEO | 2 | Hold | $17.00 | N/A | Maintains | a year ago |
Seer IncSEER | 1 | Sell | $6.50 | N/A | Downgrades | a year ago |
Icon PLCICLR | 1 | Strong Buy | $260.00 | N/A | Upgrades | a year ago |
Revvity IncRVTY | 3 | Hold | $178.00 | N/A | Downgrades | 2 years ago |
Ginkgo Bioworks Holdings IncDNA | 3 | Sell | $3.00 | N/A | Downgrades | 2 years ago |
Talis Biomedical CorpTLIS | 3 | Sell | $22.50 | N/A | Maintains | 2 years ago |
Zymergen IncZY | 1 | Sell | $7.00 | N/A | Downgrades | 3 years ago |
Lucira Health IncLHDXQ | 1 | Sell | $9.00 | N/A | Downgrades | 3 years ago |
Qiagen NvQGEN | 4 | Strong Buy | $60.77 | N/A | Upgrades | 4 years ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $156.00 | N/A | Maintains | 4 years ago |
Myriad Genetics IncMYGN | 3 | Sell | $13.00 | N/A | Reiterates | 4 years ago |
Idexx Laboratories IncIDXX | 2 | Strong Buy | $235.00 | N/A | Maintains | 5 years ago |
Zoetis IncZTS | 1 | Strong Buy | $100.00 | N/A | Maintains | 6 years ago |
Bruker CorpBRKR | 1 | Hold | $34.00 | N/A | Maintains | 6 years ago |
Abaxis IncABAX | 3 | Sell | $48.00 | N/A | Maintains | 6 years ago |
Phibro Animal Health CorpPAHC | 1 | Sell | $33.00 | N/A | Reinstates | 7 years ago |
Pra Health Sciences IncPRAH | 1 | Strong Buy | $89.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.